Myostatin, a key myokine involved in the regulation of skeletal muscle mass, has been shown to exert an immunomodulatory function in liver disease; myostatin deficiency was associated with decreased liver dysfunction and neutrophil infiltration into the liver, and improved bacterial clearance, leading to increased survival in a mouse model of sepsis.9 The gene discussed is MSTN; the disease is liver disorder.